STRIDES PHARMA SCIENCE
Back to Balance Sheet
|
STRIDES PHARMA SCIENCE Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹90 Cr | ₹145 Cr | ₹-50 Cr | ₹79 Cr | ₹-174 Cr |
What is the latest Net Current Assets ratio of STRIDES PHARMA SCIENCE ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹90 Cr |
Mar2023 | ₹145 Cr |
Mar2022 | ₹-50 Cr |
Mar2021 | ₹79 Cr |
Mar2020 | ₹-174 Cr |
How is Net Current Assets of STRIDES PHARMA SCIENCE Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹90 Cr | -38.13 | |
Mar2023 | ₹145 Cr | Positive | |
Mar2022 | ₹-50 Cr | Negative | |
Mar2021 | ₹79 Cr | Positive | |
Mar2020 | ₹-174 Cr | - |
Compare Net Current Assets of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹6,886.4 Cr | 12.3% | 15.4% | 2.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹419,764.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,010.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹118,905.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,523.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,015.0 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | 12.3% |
15.4% |
2.8% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses